These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 31952977)

  • 61. Serum High-Density Lipoprotein Cholesterol is Significantly Associated with the Presence and Severity of Pulmonary Arterial Hypertension: A Retrospective Cross-Sectional Study.
    Wang GF; Guan LH; Zhou DX; Chen DD; Zhang XC; Ge JB
    Adv Ther; 2020 May; 37(5):2199-2209. PubMed ID: 32239458
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Exercise oscillatory ventilation in heart failure and in pulmonary arterial hypertension.
    Vicenzi M; Deboeck G; Faoro V; Loison J; Vachiery JL; Naeije R
    Int J Cardiol; 2016 Jan; 202():736-40. PubMed ID: 26469553
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cystatin C: a potential biomarker for pulmonary arterial hypertension.
    Fenster BE; Lasalvia L; Schroeder JD; Smyser J; Silveira LJ; Buckner JK; Brown KK
    Respirology; 2014 May; 19(4):583-9. PubMed ID: 24628703
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Quality of Life is Related to Haemodynamics in Precapillary Pulmonary Hypertension.
    Arvanitaki A; Mouratoglou SA; Evangeliou A; Grosomanidis V; Hadjimiltiades S; Skoura L; Feloukidis C; Farmakis D; Karvounis H; Giannakoulas G
    Heart Lung Circ; 2020 Jan; 29(1):142-148. PubMed ID: 30686644
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Circulating Biomarkers in Pulmonary Arterial Hypertension: An Update.
    Correale M; Tricarico L; Bevere EML; Chirivì F; Croella F; Severino P; Mercurio V; Magrì D; Dini F; Licordari R; Beltrami M; Dattilo G; Salzano A; Palazzuoli A
    Biomolecules; 2024 May; 14(5):. PubMed ID: 38785959
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CMR-based heart deformation analysis for quantification of hemodynamics and right ventricular dysfunction in patients with CTEPH.
    Tao X; Liu M; Liu W; Xie W; Wan J; Zhai Z; Wang C
    Clin Respir J; 2020 Mar; 14(3):277-284. PubMed ID: 31814279
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
    Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
    Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pulmonary arterial hypertension with below threshold pulmonary vascular resistance.
    Ratwatte S; Anderson J; Strange G; Corrigan C; Collins N; Celermajer DS; Dwyer N; Feenstra J; Keating D; Kotlyar E; Lavender M; Whitford H; Whyte K; Williams T; Wrobel JP; Keogh A; Lau EM;
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32341105
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pulmonary Hypertension in Hereditary Hemorrhagic Telangiectasia.
    Lyle MA; Fenstad ER; McGoon MD; Frantz RP; Krowka MJ; Kane GC; Swanson KL
    Chest; 2016 Feb; 149(2):362-371. PubMed ID: 26204445
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Elevation of plasma cell-free hemoglobin in pulmonary arterial hypertension.
    Brittain EL; Janz DR; Austin ED; Bastarache JA; Wheeler LA; Ware LB; Hemnes AR
    Chest; 2014 Dec; 146(6):1478-1485. PubMed ID: 24945582
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension.
    Parikh KS; Dahhan T; Nicholl L; Ruopp N; Pomann GM; Fortin T; Tapson VF; Rajagopal S
    Sci Rep; 2019 Mar; 9(1):4061. PubMed ID: 30858405
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Right ventricular performance in arterial hypertension.
    Neubaur T; Schwartzkopff B; Strauer BE
    Eur Heart J; 1992 Sep; 13 Suppl D():33-8. PubMed ID: 1396857
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
    Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
    Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Assessment of the hemodynamics of pulmonary artery and right ventricular function in chronic obstructive pulmonary disease with pulmonary hypertension using cardiac magnetic resonance imaging].
    Fan Y; Guo X; Sun X; Cao X; He J; Zhu L; Chen J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2019 Aug; 31(8):972-977. PubMed ID: 31537222
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Noninvasive wave intensity analysis predicts functional worsening in children with pulmonary arterial hypertension.
    Schäfer M; Wilson N; Ivy DD; Ing R; Abman S; Browne LP; Morgan G; Ross M; McLennan D; Barker AJ; Fonseca B; Di Maria M; Hunter KS; Truong U
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H968-H977. PubMed ID: 30004811
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Survival in rheumatoid arthritis-associated pulmonary arterial hypertension compared with idiopathic pulmonary arterial hypertension.
    Sadeghi S; Granton JT; Akhavan P; Pasarikovski CR; Roos AM; Thenganatt J; Moric J; Johnson SR
    Respirology; 2015 Apr; 20(3):481-7. PubMed ID: 25583377
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment goals of pulmonary hypertension.
    McLaughlin VV; Gaine SP; Howard LS; Leuchte HH; Mathier MA; Mehta S; Palazzini M; Park MH; Tapson VF; Sitbon O
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D73-81. PubMed ID: 24355644
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension.
    Richter MJ; Tiede SL; Sommer N; Schmidt T; Seeger W; Ghofrani HA; Schermuly R; Gall H
    PLoS One; 2016; 11(11):e0165982. PubMed ID: 27802345
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension.
    Kylhammar D; Kjellström B; Hjalmarsson C; Jansson K; Nisell M; Söderberg S; Wikström G; Rådegran G
    Eur Heart J; 2018 Dec; 39(47):4175-4181. PubMed ID: 28575277
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Long-Term Outcomes in Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension in the Modern Treatment Era: Meta-Analyses of Randomized, Controlled Trials and Observational Registries.
    Khanna D; Zhao C; Saggar R; Mathai SC; Chung L; Coghlan JG; Shah M; Hartney J; McLaughlin V
    Arthritis Rheumatol; 2021 May; 73(5):837-847. PubMed ID: 33538058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.